Results 261 to 270 of about 40,984 (314)

Dexmedetomidine as a Total Intravenous Anesthetic Agent

Anesthesiology, 2004
DEXMEDETOMIDINE is a highly selective α 2 adrenoceptor agonist that has sedative and analgesic properties with associated reduction in opioid and anesthetic requirements. 1-11 One significant advantage of dexmedetomidine is that in the clinical dose range there is no respiratory depression. 12-14 The agonistic action on the α 2 adrenoceptors in the
David L. Luterman, Michael A. E. Ramsay
openaire   +3 more sources

Pharmacology of Intravenous Anesthetic Agents

2010
Learn the relative advantages of each of the commonly used intravenous induction agents (propofol, etomidate, ketamine, thiopental) iscuss the pharmacokinetic properties of each of the commonly used intravenous opioids (fentanyl, morphine, hydromorphone, remifentanil) Understand the differences between depolarizing and nondepolarizing neuromuscular ...
Jerome M. Adams, John W. Wolfe
openaire   +2 more sources

Intravenous Anesthetics in the Pulmonary Circulation

2000
Intravenous anesthetics in either bolus or constant infusion may be used to produce induction or maintenance of anesthesia. Examples of these anesthetics are ultra-short-acting thiobarbiturates, propofol, etomidate, and ketamine. Of the four, propofol and ketamine possess significant pulmonary effects.
Alan D. Kaye, Bobby D. Nossaman, Philip J. Kadowitz   +2 more
openaire   +2 more sources

What’s New in Intravenous Anesthetics?

Anesthesiology Clinics of North America, 1988
Summary It is obvious that many of the goals desirable in an ideal IV induction agent have not been achieved with the currently available drugs. An ideal drug for induction of anesthesia would provide for a rapid and pleasant loss of consciousness, no cardiorespiratory changes, good operating conditions, and a rapid recovery without side effects ...
openaire   +2 more sources

Mechanisms of Intravenous Anesthetic Action

2017
General anesthesia consists of key separable and independent neurobiological end points. Each of these involves distinct but possibly overlapping neuroanatomical and molecular mechanisms that converge to produce the characteristic behavioral end points of anesthesia: amnesia, unconsciousness, and immobility.
Hugh C. Hemmings, Karl F. Herold
openaire   +2 more sources

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine, 2023
Roland Bassett Jr, Rodabe N Amaria, Cassian Yee   +2 more
exaly  

Intravenous Anesthetic Agents

2008
Anthony Absalom, Tamsin Poole
openaire   +3 more sources

AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset

Nature Neuroscience, 2021
Nicholas C Flytzanis, Yangyang Duan, Liping Wang   +2 more
exaly  

Intravenous Anesthetics

2013
Peter S. Sebel, Matthew K. Whalin, Paul S. García   +2 more
openaire   +2 more sources

Prevention of tuberculosis in macaques after intravenous BCG immunization

Nature, 2020
Patricia A Darrah, Pauline Maiello, Mark A Rodgers   +2 more
exaly